Mitchell Stark

13.2k citations

68 papers · 7.7k · 2 hit papers · h-index 27

Impact in

Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Molecular Biology top 1%
- Bioinformatics and Genomic Networks
- Melanoma and MAPK Pathways
- RNA modifications and cancer

Papers in

Molecular Biology 39
- Melanoma and MAPK Pathways 15
- Epigenetics and DNA Methylation 5
- Genomics and Chromatin Dynamics 4
Oncology 25
- Cutaneous Melanoma Detection and Management 21

Co-authors: Milan Simonovic (2 shared papers)Peer Bork (2 shared papers)Alexander Röth (2 shared papers)Tobias Doerks (2 shared papers)Jean Muller (2 shared papers)Christian von Mering (2 shared papers)Michael Kuhn (2 shared papers)Lars Juhl Jensen (2 shared papers)
Journals: British Journal of Dermatology (7 papers)Journal of Investigative Dermatology (6 papers)Genes Chromosomes and Cancer (4 papers)PLoS ONE (4 papers)Pigment Cell & Melanoma Research (4 papers)
Partner nations: Australia United States United Kingdom

In The Last Decade

Mitchell Stark

64 papers receiving 7.6k citations

Mitchell Stark's Hit Papers

align trajectories log scale

The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored 2010 · 2.9k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2010 Nucleic Acids Research
2008 Nucleic Acids Research

Peers

Countries citing papers authored by Mitchell Stark

Since Specialization

Citations

This map shows the geographic impact of Mitchell Stark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell Stark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell Stark more than expected).

Fields of papers citing papers by Mitchell Stark

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell Stark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell Stark. The network helps show where Mitchell Stark may publish in the future.

Co-authors

The 25 scholars most cited alongside Mitchell Stark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mitchell Stark Line = papers co-authored together Mitchell Stark links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored Nucleic Acids Research ·Damian Szklarczyk, Andrea Franceschini, Michael Kuhn, Milan Simonovic, Alexander Röth, Pablo Mínguez, Tobias Doerks, Mitchell Stark, Jean Muller, Peer Bork, Lars Juhl Jensen, Christian von Mering Hit paper breakdown →	2010	2873
2	STRING 8--a global view on proteins and their functional interactions in 630 organisms Nucleic Acids Research ·Lars Juhl Jensen, Michael Kuhn, Mitchell Stark, Samuel Chaffron, Christopher J. Creevey, Jean Muller, Tobias Doerks, P. Julien, Alexander Röth, Milan Simonovic, Peer Bork, Christian von Mering Hit paper breakdown →	2008	2010
3	A Single SNP in an Evolutionary Conserved Region within Intron 86 of the HERC2 Gene Determines Human Blue-Brown Eye Color The American Journal of Human Genetics ·Richard A. Sturm, David L. Duffy, Zhen Zhao, Fabio P.N. Leite, Mitchell Stark, Nicholas K. Hayward, Nicholas G. Martin, Grant W. Montgomery	2008	278
4	MC1R Genotype Modifies Risk of Melanoma in Families Segregating CDKN2A Mutations The American Journal of Human Genetics ·Neil F. Box, David L. Duffy, Wei Chen, Mitchell Stark, Nicholas G. Martin, Richard A. Sturm, Nicholas K. Hayward	2001	235
5	Genome-Wide Loss of Heterozygosity and Copy Number Analysis in Melanoma Using High-Density Single-Nucleotide Polymorphism Arrays Cancer Research ·Mitchell Stark, Nicholas K. Hayward	2007	180
6	Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS British Journal of Cancer ·Wieke Zuidervaart, Frans van Nieuwpoort, Mitchell Stark, Remco Dijkman, Leisl Packer, A. M. Borgstein, Sandra Pavey, Pieter van der Velden, Coby Out, Martine J. Jager, Nicholas K. Hayward, Nelleke A. Gruis	2005	179
7	Characterization of the Melanoma miRNAome by Deep Sequencing PLoS ONE ·Mitchell Stark, Sonika Tyagi, Derek J. Nancarrow, Glen M. Boyle, Anthony L. Cook, David C. Whiteman, Peter G. Parsons, Christopher Schmidt, Richard A. Sturm, Nicholas K. Hayward	2010	168
8	Melanoma cell invasiveness is regulated by miR‐211 suppression of the BRN2 transcription factor Pigment Cell & Melanoma Research ·Glen M. Boyle, Susan L. Woods, Vanessa Bonazzi, Mitchell Stark, Elke Hacker, Lauren G. Aoude, Ken Dutton‐Regester, Anthony L. Cook, Richard A. Sturm, Nicholas K. Hayward	2011	148
9	Microarray expression profiling in melanoma reveals a BRAF mutation signature Oncogene ·Sandra Pavey, Peter A. Johansson, Leisl Packer, Jennifer M. Taylor, Mitchell Stark, Pamela M. Pollock, Graeme J. Walker, Glen M. Boyle, Ursula L. Harper, Sarah‐Jane Cozzi, Katherine Hansen, Laura M. Yudt, Christopher Schmidt, Peter Hersey, K.A.O. Ellem, Michael G. E. OʼRourke, Peter G. Parsons, Paul Meltzer, Markus Ringnér, Nicholas K. Hayward	2004	141
10	Conditional Inactivation of the Men1 Gene Leads to Pancreatic and Pituitary Tumorigenesis but Does Not Affect Normal Development of These Tissues Molecular and Cellular Biology ·Christine Biondi, Michael G. Gartside, Paul Waring, Kelly A. Loffler, Mitchell Stark, Mark A. Magnuson, Graham F. Kay, Nicholas K. Hayward	2004	111
11	Association of Helicobacter pylori Infection With Reduced Risk for Esophageal Cancer Is Independent of Environmental and Genetic Modifiers Gastroenterology ·David C. Whiteman, Priya Parmar, Paul Fahey, Suzanne Moore, Mitchell Stark, Zhen Zhao, Grant W. Montgomery, Adèle C. Green, Nicholas K. Hayward, Penelope M. Webb	2010	103
12	The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis EBioMedicine ·Mitchell Stark, Kerenaftali Klein, Benjamin Weide, Lauren E. Haydu, Annette Pflugfelder, Yue Tang, Jane M. Palmer, David C. Whiteman, Richard A. Scolyer, Graham J. Mann, John F. Thompson, Georgina V. Long, Andrew P. Barbour, H. Peter Soyer, Claus Garbe, Adrian C. Herington, Pamela M. Pollock, Nicholas K. Hayward	2015	87
13	miR-514a regulates the tumour suppressor NF1 and modulates BRAFi sensitivity in melanoma Oncotarget ·Mitchell Stark, Vanessa Bonazzi, Glen M. Boyle, Jane M. Palmer, Judith Symmons, Catherine Lanagan, Christopher Schmidt, Adrian C. Herington, Robert Ballotti, Pamela M. Pollock, Nicholas K. Hayward	2015	81
14	Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1 International Journal of Cancer ·Kelly A. Loffler, Christine Biondi, Michael G. Gartside, Paul Waring, Mitchell Stark, Magdalena M. Serewko-Auret, H. Konrad Muller, Nicholas K. Hayward, Graham F. Kay	2006	75
15	Cross-Platform Array Screening Identifies COL1A2, THBS1, TNFRSF10D and UCHL1 as Genes Frequently Silenced by Methylation in Melanoma PLoS ONE ·Vanessa Bonazzi, Derek J. Nancarrow, Mitchell Stark, Ralf Moser, Glen M. Boyle, Lauren G. Aoude, Christopher Schmidt, Nicholas K. Hayward	2011	73
16	Smchd1 regulates a subset of autosomal genes subject to monoallelic expression in addition to being critical for X inactivation Epigenetics & Chromatin ·Arne W. Mould, Zhenyi Pang, Miha Pakusch, Ian D. Tonks, Mitchell Stark, (unknown), Pamela Mukhopadhyay, Annica Seidel, Jonathan J. Ellis, Janine E. Deakin, Matthew J. Wakefield, Lutz Krause, Marnie E. Blewitt, Graham F. Kay	2013	73
17	An Integrated Microfluidic‐SERS Platform Enables Sensitive Phenotyping of Serum Extracellular Vesicles in Early Stage Melanomas Advanced Functional Materials ·Jing Wang, Y. Kao, Quan Zhou, Alain Wuethrich, Mitchell Stark, Helmut Schaider, H. Peter Soyer, Lynlee L. Lin, Matt Trau	2021	69
18	MicroRNA regulation of melanoma progression Melanoma Research ·Vanessa Bonazzi, Mitchell Stark, Nicholas K. Hayward	2011	58
19	Polymorphisms in MGMT and DNA repair genes and the risk of esophageal adenocarcinoma International Journal of Cancer ·James D. Doecke, Zhen Zhao, Nirmala Pandeya, Shahram Sadeghi, Mitchell Stark, Adèle C. Green, Nicholas K. Hayward, Penelope M. Webb, David C. Whiteman, (unknown)	2008	57
20	MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis Pigment Cell & Melanoma Research ·Varsha Tembe, Sarah‐Jane Schramm, Mitchell Stark, Ellis Patrick, Vivek Jayaswal, Yue Tang, Andrew P. Barbour, Nicholas K. Hayward, John F. Thompson, Richard A. Scolyer, (unknown), Graham J. Mann	2014	57

About Mitchell Stark

Mitchell Stark is a scholar working on Molecular Biology, Oncology, Cancer Research, Cell Biology and Dermatology, having authored 68 papers that have together received 7.7k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (21 papers), Melanoma and MAPK Pathways (15 papers), Cancer Genomics and Diagnostics (13 papers), melanin and skin pigmentation (10 papers), MicroRNA in disease regulation (8 papers), Epigenetics and DNA Methylation (5 papers), Skin Protection and Aging (4 papers) and Genomics and Chromatin Dynamics (4 papers). The work is most often cited by research in Cancer Research (1.1k citations), Molecular Biology (4.7k citations), Cell Biology (756 citations), Oncology (1.1k citations) and Immunology (606 citations). Mitchell Stark has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Milan Simonovic, Peer Bork, Alexander Röth, Tobias Doerks, Jean Muller, Christian von Mering, Michael Kuhn, Lars Juhl Jensen, Nicholas K. Hayward and Pablo Mínguez. Their work appears in journals such as British Journal of Dermatology, Journal of Investigative Dermatology, Genes Chromosomes and Cancer, PLoS ONE and Pigment Cell & Melanoma Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Mitchell Stark

Impact in

Papers in i

In The Last Decade

Mitchell Stark

Mitchell Stark's Hit Papers

Peers

Countries citing papers authored by Mitchell Stark

Fields of papers citing papers by Mitchell Stark

All Works

About Mitchell Stark

Explore authors with similar magnitude of impact

Papers in